suPARnostic® TurbiLatex for rapid and high volume suPAR detection

About suPARnostic® TurbiLatex

The suPARnostic® TurbiLatex is a CE-IVD approved particle-enhanced turbidimetric immunoassay (PETIA) for quantitative measurement of suPAR in human plasma (K2-EDTA or lithium heparin).

Validated on leading automated chemistry platforms, including Roche Cobas, Siemens Atellica, Abbott Architect/Alinity, and Beckman Coulter systems, it delivers fast and reliable results to support clinical decision making.

suPAR is the soluble form of uPAR (urokinase plasminogen activator receptor), a strong biomarker of immune activation and inflammation that elevates with disease presence and severity.

Read more about suPAR here.

suPARnostic® TurbiLatex

Important clinical benefits of suPAR:

  • Aid in prioritization of patients who can be discharged after treatment
  • Assistance in the identification of high-risk patients with unaffected vital signs
  • Shortens the average patient-length-of-stay and reduces the cost of healthcare

How the suPARnostic® TurbiLatex Works

The suPARnostic® TurbiLatex is a particle-enhanced turbidimetric immunoassay that measures suPAR levels in plasma (K2-EDTA or lithium heparin). The test uses latex particles coated with antibodies that bind specifically to suPAR. Binding of suPAR to these antibody-coated latex particles leads to agglutinated, aggregated immune complexes, which increases turbidity (scattering of light). This turbidity is measured photometrically on automated clinical chemistry analysers (e.g. Roche Cobas, Siemens Atellica, Abbott Architect, etc.).

Why choose suPARnostic® TurbiLatex?

  • Fast & automated: The assay delivers results in about 10 minutes on routine clinical chemistry analysers.
  • Validated & CE-IVD approved: suPARnostic® TurbiLatex is a quantitative, CE-marked in vitro diagnostic test, validated on multiple major platforms including Roche cobas®, Abbott Architect, Siemens, and Beckman Coulter systems.
  • Supports clinical decisions: By quantifying suPAR levels, the test aids in risk stratification, triage decisions, and prognosis in some cases for patients in the Emergency Department (ED) and Intensive Care Unit (ICU). suPAR is a strong biomarker of inflammation, immune activation, and disease progression.
  • Reliable performance: Delivers precise and consistent results across the validated measuring range (1.8–16.0 ng/mL) with demonstrated linearity up to 26.5 ng/mL. The assay shows no prozone effect at clinically relevant concentrations, ensuring accuracy even in high suPAR samples.
  • Integrated quality control: Routine use of calibrators (#T020) and controls (#T030) ensures accuracy and reproducibility of results, with calibration recommended at least monthly and after each new reagent lot.
  • Improves patient management: Clinical studies show that high suPAR (6. ng/mL) identifies patients at higher risk of adverse outcomes, enabling targeted resource allocation with their respective health economic impacts.

Product Details

TurbiLatex test

The suPARnostic® TurbiLatex test is a latex particle-enhanced turbidimetric immunoassay that quantitatively determines the suPAR level in human K2-EDTA- or Lithium Heparin plasma samples.

The suPARnostic® TurbiLatex product is validated for the Roche Diagnostics Cobas c111, c303, c501/2, c701/2, Pure and Pro systems, the Siemens Atellica, and ADVIA Chemistry XPT, the Abbott Architect c, and Alinity ci systems and Beckman Coulter 5800.

Format: Ready-to-use two-reagent kit (Reagent 1: Dilution buffer; Reagent 2: Latex particle reagent)
Assay Time
: 10 minutes
Sample Type: Human K2-EDTA plasma; Human Lithium-Heparin plasma
Measuring Range: 1.8–16.0 ng/mL
Reagent Shelf Life: 2 years

Product contains

  • Reagent 1: Dilution Buffer
  • Reagent 2: Latex Particles coated with anti-suPAR antibodies

Product Code

Product no. T001 : suPARnostic® TurbiLatex Reagents

Documentation

See technical documents

Product Details

TurbiLatex Reagents

Quality control of the suPARnostic® TurbiLatex Reagents should be performed with the suPARnostic® TurbiLatex Controls.

Quality control should be performed according to the laboratory guidelines. Ranges and limits should be fitted to the specific laboratory’s experience and knowledge.

Format: 3 Ready-to-use controls (1 mL each)
Calibrator Shelf Life:  12 months;

Product contains

  • 1 mL of each Control 1-3 (Low, Medium, High suPAR level)
  • Certificate of analysis with concentrations is provided with each kit

Product Code

Product no. T030: suPARnostic® TurbiLatex Controls

Documentation

See technical documents

Product DetailsTurbiLatex Reagents

Together with the suPARnostic® TurbiLatex Reagents, the suPARnostic® TurbiLatex Calibrators should be used for calibration.

It is recommended to repeat the calibration at least once a month. In addition, it is required to recalibrate when a new batch of the suPARnostic® TurbiLatex Reagents is used.

The suPARnostic® Calibrators are used to establish a calibration curve which is used to interpolate the suPAR measurements.

Format: six ready-to-use liquid calibrators, 1 mL each
Calibrator Shelf Life: 12 months

The product contains

  • 1 mL of each Calibrator

Product Code

Product no. T020: suPARnostic® TurbiLatex Calibrators

Documentation

See technical documents

Want to buy suPARnostic® TurbiLatex?

FAQs

suPAR is the soluble urokinase plasminogen activator receptor — a circulating form of the receptor (uPAR) that can reflect immune activation and inflammation.

It is a particle‑enhanced turbidimetric immunoassay (PETIA) for quantitative measurement of suPAR in human K2‑EDTA or lithium heparin plasma, intended for use with automated clinical chemistry analyzers.

It is validated for EDTA plasma and lithium heparin plasma.

No — The TurbiLatex suPAR test works on plasma only and does not validate serum for this assay.

The measuring (reportable) range is 1.8 to 16.0 ng/mL. The assay is linear up to 26.5 ng/mL.

The assay shows no prozone effect up to ~47.5 ng/mL (depending on the analyzer

The number of tests supported per kit depends on the analyzer and its application parameters. The detailed test capacity for each analyzer is provided in the Instruction For Use. These values already take into account calibration and dead volume.

Calibrators: Six ready-to-use buffer-based solutions, stored frozen at –18 to –20 °C, with a shelf life of 12 months.

Controls: Three ready-to-use buffer-based suPAR solutions (low, medium, high), stored frozen at –18 to –20 °C, with a shelf life of 12 months.

Calibration is recommended at least monthly, and mandatory when a new reagent lot is used.

At room temperature (20–25 °C): stable for 24 hours
At 2–8 °C: stable for 3 days
Frozen (≤ –20 °C): for longer storage

The total runtime is ~10 minutes on supported analyzers.

Validated on Roche cobas (c111, c303, c501/2, c701/2, Pure/Pro), Siemens Atellica/ADVIA Chemistry, Abbott Architect/Alinity, Beckman Coulter AU/DxC 5800.

The maximum allowed variation between ELISA and TurbiLatex is 15%, and between TurbiLatex lots, 10%. Correlation coefficient ~0.96 in comparative studies.

Yes. The assay is calibrated for K2-EDTA. For lithium heparin plasma, there is a minor bias; one correction formula is provided in the Instructions For Use.

In healthy blood donors (n ≈ 9,305):

  • Men 18–65 years median ~ 2.22 ng/mL (25‑75%: 1.76–2.90)
  • Women 18–65 years median ~ 2.56 ng/mL (25‑75%: 2.05–3.23)

Commonly:

  • <4.0 – Low Risk:
    Supports discharge; good prognosis; low risk of respiratory failure.
  • 4.0–6.0 – Medium Risk:
    Indicates some disease activity/comorbidity; moderate risk of readmission or respiratory failure.
  • 6.0 – High Risk:
    Admission and treatment recommended; high risk of mortality and respiratory failure.

Reagents: 2–8 °C, shelf life 24 months, onboard stability ~8 weeks
Calibrators: frozen (–18 to –20 °C), shelf life ~12 months
Controls: frozen (–18 to –20 °C), shelf life ~12 months

The suPARnostic® brand consists of three products:

Quick Triage

A Point of Care Solution

Quick Triage

Turbi-Latex

For Automated Systems

TurbiLatex

ELISA Assay

Clinical and Research

ELISA

Read 1000+ published suPAR studies in leading medical journals

suPAR and inflammation in Nature Medicine medical and scientific Journal
suPAR and inflammation in The New England Journal of Medicine
suPAR and inflammation in Science AAAS Journal
suPAR and inflammation in JAMA medical and scientific journal
suPARnostic® by ViroGates